Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Metabolic consequences of long-term rapamycin exposure on common marmoset monkeys (Callithrix jacchus).

Ross C, Salmon A, Strong R, Fernandez E, Javors M, Richardson A, Tardif S.

Aging (Albany NY). 2015 Nov;7(11):964-73.

2.

Testing efficacy of administration of the antiaging drug rapamycin in a nonhuman primate, the common marmoset.

Tardif S, Ross C, Bergman P, Fernandez E, Javors M, Salmon A, Spross J, Strong R, Richardson A.

J Gerontol A Biol Sci Med Sci. 2015 May;70(5):577-87. doi: 10.1093/gerona/glu101. Epub 2014 Jul 19.

3.

Pharmaceutical inhibition of mTOR in the common marmoset: effect of rapamycin on regulators of proteostasis in a non-human primate.

Lelegren M, Liu Y, Ross C, Tardif S, Salmon AB.

Pathobiol Aging Age Relat Dis. 2016 Jun 23;6:31793. doi: 10.3402/pba.v6.31793. eCollection 2016.

4.

Characterization of obese phenotypes in a small nonhuman primate, the common marmoset (Callithrix jacchus).

Tardif SD, Power ML, Ross CN, Rutherford JN, Layne-Colon DG, Paulik MA.

Obesity (Silver Spring). 2009 Aug;17(8):1499-505. doi: 10.1038/oby.2009.77. Epub 2009 Mar 26.

5.

Long-term treatment with the mTOR inhibitor rapamycin has minor effect on clinical laboratory markers in middle-aged marmosets.

Sills AM, Artavia JM, DeRosa BD, Ross CN, Salmon AB.

Am J Primatol. 2019 Feb;81(2):e22927. doi: 10.1002/ajp.22927. Epub 2018 Oct 12.

6.

Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats.

Deblon N, Bourgoin L, Veyrat-Durebex C, Peyrou M, Vinciguerra M, Caillon A, Maeder C, Fournier M, Montet X, Rohner-Jeanrenaud F, Foti M.

Br J Pharmacol. 2012 Apr;165(7):2325-40. doi: 10.1111/j.1476-5381.2011.01716.x.

7.

The development of a specific pathogen free (SPF) barrier colony of marmosets (Callithrix jacchus) for aging research.

Ross CN, Austad S, Brasky K, Brown CJ, Forney LJ, Gelfond JA, Lanford R, Richardson A, Tardif SD.

Aging (Albany NY). 2017 Dec 7;9(12):2544-2558. doi: 10.18632/aging.101340.

8.

A longitudinal analysis of the effects of age on the blood plasma metabolome in the common marmoset, Callithrix jacchus.

Hoffman JM, Tran V, Wachtman LM, Green CL, Jones DP, Promislow DE.

Exp Gerontol. 2016 Apr;76:17-24. doi: 10.1016/j.exger.2016.01.007. Epub 2016 Jan 21.

9.

Qualitative de novo analysis of full length cDNA and quantitative analysis of gene expression for common marmoset (Callithrix jacchus) transcriptomes using parallel long-read technology and short-read sequencing.

Shimizu M, Iwano S, Uno Y, Uehara S, Inoue T, Murayama N, Onodera J, Sasaki E, Yamazaki H.

PLoS One. 2014 Jun 30;9(6):e100936. doi: 10.1371/journal.pone.0100936. eCollection 2014.

10.

Life span of common marmoset (Callithrix jacchus) at CLEA Japan breeding colony.

Nishijima K, Saitoh R, Tanaka S, Ohsato-Suzuki M, Ohno T, Kitajima S.

Biogerontology. 2012 Aug;13(4):439-43. doi: 10.1007/s10522-012-9388-1. Epub 2012 Jul 3.

PMID:
22752736
11.

Using snacks high in fat and protein to improve glucoregulatory function in adolescent male marmosets (Callithrix jacchus).

Ziegler TE, Sosa ME, Peterson LJ, Colman RJ.

J Am Assoc Lab Anim Sci. 2013 Nov;52(6):756-62.

12.

Metabolic consequences of the early onset of obesity in common marmoset monkeys.

Power ML, Ross CN, Schulkin J, Ziegler TE, Tardif SD.

Obesity (Silver Spring). 2013 Dec;21(12):E592-8. doi: 10.1002/oby.20462. Epub 2013 Jun 22.

13.

Differential contribution of dietary fat and monosaccharide to metabolic syndrome in the common marmoset (Callithrix jacchus).

Wachtman LM, Kramer JA, Miller AD, Hachey AM, Curran EH, Mansfield KG.

Obesity (Silver Spring). 2011 Jun;19(6):1145-56. doi: 10.1038/oby.2010.303. Epub 2010 Dec 16.

14.

The common marmoset (Callithrix jacchus) as a model in toxicology.

Z├╝hlke U, Weinbauer G.

Toxicol Pathol. 2003 Jan-Feb;31 Suppl:123-7. Review.

PMID:
12597440
15.

Evaluation of the pharmacokinetics of metformin and acarbose in the common marmoset.

Fernandez E, Ross C, Liang H, Javors M, Tardif S, Salmon AB.

Pathobiol Aging Age Relat Dis. 2019 Aug 22;9(1):1657756. doi: 10.1080/20010001.2019.1657756. eCollection 2019.

16.

Beneficial metabolic effects of rapamycin are associated with enhanced regulatory cells in diet-induced obese mice.

Makki K, Taront S, Molendi-Coste O, Bouchaert E, Neve B, Eury E, Lobbens S, Labalette M, Duez H, Staels B, Dombrowicz D, Froguel P, Wolowczuk I.

PLoS One. 2014 Apr 7;9(4):e92684. doi: 10.1371/journal.pone.0092684. eCollection 2014.

17.

Long-term administration of rapamycin reduces adiposity, but impairs glucose tolerance in high-fat diet-fed KK/HlJ mice.

Chang GR, Wu YY, Chiu YS, Chen WY, Liao JW, Hsu HM, Chao TH, Hung SW, Mao FC.

Basic Clin Pharmacol Toxicol. 2009 Sep;105(3):188-98. doi: 10.1111/j.1742-7843.2009.00427.x. Epub 2009 May 26.

18.

Body mass growth in common marmosets: toward a model of pediatric obesity.

Tardif SD, Power ML, Ross CN, Rutherford JN.

Am J Phys Anthropol. 2013 Jan;150(1):21-8. doi: 10.1002/ajpa.22110.

19.

Molecular signatures to define spermatogenic cells in common marmoset (Callithrix jacchus).

Lin ZY, Imamura M, Sano C, Nakajima R, Suzuki T, Yamadera R, Takehara Y, Okano HJ, Sasaki E, Okano H.

Reproduction. 2012 May;143(5):597-609. doi: 10.1530/REP-11-0215. Epub 2012 Feb 8.

PMID:
22323619
20.

Positron emission tomography assessment of 8-OH-DPAT-mediated changes in an index of cerebral glucose metabolism in female marmosets.

Converse AK, Aubert Y, Farhoud M, Weichert JP, Rowland IJ, Ingrisano NM, Allers KA, Sommer B, Abbott DH.

Neuroimage. 2012 Mar;60(1):447-55. doi: 10.1016/j.neuroimage.2011.12.065. Epub 2012 Jan 2.

Supplemental Content

Support Center